Literature DB >> 11585809

Requirement of NF-kappaB/Rel for the development of hair follicles and other epidermal appendices.

R Schmidt-Ullrich1, T Aebischer, J Hülsken, W Birchmeier, U Klemm, C Scheidereit.   

Abstract

NF-kappaB/Rel transcription factors and IkappaB kinases (IKK) are essential for inflammation and immune responses, but also for bone-morphogenesis, skin proliferation and differentiation. Determining their other functions has previously been impossible, owing to embryonic lethality of NF-kappaB/Rel or IKK-deficient animals. Using a gene targeting approach we have ubiquitously expressed an NF-kappaB super-repressor to investigate NF-kappaB functions in the adult. Mice with suppressed NF-kappaB revealed defective early morphogenesis of hair follicles, exocrine glands and teeth, identical to Eda (tabby) and Edar (downless) mutant mice. These affected epithelial appendices normally display high NF-kappaB activity, suppression of which resulted in increased apoptosis, indicating that NF-kappaB acts as a survival factor downstream of the tumor necrosis factor receptor family member EDAR. Furthermore, NF-kappaB is required for peripheral lymph node formation and macrophage function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585809     DOI: 10.1242/dev.128.19.3843

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  82 in total

1.  Hair follicle morphogenesis and epidermal homeostasis in we/we wal/wal mice with postnatal alopecia.

Authors:  Alexandra Rippa; Vasily Terskikh; Anastasia Nesterova; Andrey Vasiliev; Ekaterina Vorotelyak
Journal:  Histochem Cell Biol       Date:  2014-11-04       Impact factor: 4.304

2.  Phospholipase Cdelta1 is required for skin stem cell lineage commitment.

Authors:  Yoshikazu Nakamura; Kiyoko Fukami; Haiyan Yu; Kei Takenaka; Yuki Kataoka; Yuji Shirakata; Shin-Ichi Nishikawa; Koji Hashimoto; Nobuaki Yoshida; Tadaomi Takenawa
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

3.  Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.

Authors:  M Sisto; A Barca; D D Lofrumento; S Lisi
Journal:  Clin Exp Immunol       Date:  2016-02-23       Impact factor: 4.330

Review 4.  The mammary bud as a skin appendage: unique and shared aspects of development.

Authors:  Marja L Mikkola; Sarah E Millar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-10       Impact factor: 2.673

Review 5.  EDA signaling and skin appendage development.

Authors:  Chang-Yi Cui; David Schlessinger
Journal:  Cell Cycle       Date:  2006-09-14       Impact factor: 4.534

6.  Critical role for NF-kappaB-induced JunB in VEGF regulation and tumor angiogenesis.

Authors:  Dirk Schmidt; Björn Textor; Oliver T Pein; Alexander H Licht; Sven Andrecht; Melanie Sator-Schmitt; Norbert E Fusenig; Peter Angel; Marina Schorpp-Kistner
Journal:  EMBO J       Date:  2007-01-25       Impact factor: 11.598

7.  Nuclear factor-kappaB activation in neonatal mouse lung protects against lipopolysaccharide-induced inflammation.

Authors:  Cristina M Alvira; Aida Abate; Guang Yang; Phyllis A Dennery; Marlene Rabinovitch
Journal:  Am J Respir Crit Care Med       Date:  2007-01-25       Impact factor: 21.405

8.  Drosophila Rel proteins are central regulators of a robust, multi-organ immune network.

Authors:  Nina Matova; Kathryn V Anderson
Journal:  J Cell Sci       Date:  2010-02-15       Impact factor: 5.285

9.  Cytomegalovirus inhibition of embryonic mouse tooth development: a model of the human amelogenesis imperfecta phenocopy.

Authors:  Tina Jaskoll; George Abichaker; Nolan Jangaard; Pablo Bringas; Michael Melnick
Journal:  Arch Oral Biol       Date:  2008-01-16       Impact factor: 2.633

10.  Activation of the NF-kappaB pathway in human cytomegalovirus-infected cells is necessary for efficient transactivation of the major immediate-early promoter.

Authors:  Ian B DeMeritt; Liesl E Milford; Andrew D Yurochko
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.